These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37594355)

  • 1. A case of anti-SAE antibody-positive clinically amyopathic dermatomyositis complicated by advanced gastric cancer and interstitial lung disease.
    Kudo K; Hamaguchi Y; Iyobe R; Kitano T; Maeda S; Kinoshita J; Inaki N; Ohkura N; Fujii K; Taniuchi K; Matsushita T
    Eur J Dermatol; 2023 Jun; 33(3):323-325. PubMed ID: 37594355
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
    McPherson M; Economidou S; Liampas A; Zis P; Parperis K
    Semin Arthritis Rheum; 2022 Apr; 53():151959. PubMed ID: 35134633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.
    Yamaoka T; Doi C; Yokomi A; Tanemura A; Murota H; Tani M; Saruban H; Hamaguchi Y; Fujimoto M; Katayama I
    Eur J Dermatol; 2014; 24(4):490-1. PubMed ID: 25075604
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease.
    Horino T; Inotani S; Nakajima K; Ohnishi H; Komori M; Terada Y
    Joint Bone Spine; 2022 Nov; 89(6):105456. PubMed ID: 36108903
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease.
    Sugimoto T; Hajiro T; Fujimoto T; Kojyo N; Horie M; Kashiwagi A
    Lupus; 2007; 16(12):1004-5. PubMed ID: 18042598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinically amyopathic dermatomyositis : a rare entity associated with acute and severe interstitial lung disease].
    Debrus C; Calmes D; Von Frenckell C; Duysinx B; Cataldo D; Corhay JL; Louis R; Guiot J
    Rev Med Liege; 2023 Jul; 78(7-8):441-447. PubMed ID: 37560958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y; Aya Y; Megumi U; Shunichi K; Masafumi S; Hiroaki M; Masahiko K; Shinsuke K; Manabu U; Kenichiro H; Fumiaki A; Nozomi A; Toshitaka M; Masayoshi Y; Chikako K; Yoshinao M; Tatsuo S; Masahiko K
    Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-transcription intermediary factor 1-γ antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer.
    Ogawa M; Sugiura K; Yokota K; Muro Y; Akiyama M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):373-5. PubMed ID: 25346167
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
    Hayashi M; Kikuchi T; Takada T
    Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
    [No Abstract]   [Full Text] [Related]  

  • 10. An Autopsy Case of Anti-melanoma Differentiation-associated Gene-5 Antibody-positive Clinical Amyopathic Dermatomyositis Complicated by Rapidly Progressive Interstitial Lung Disease.
    Yoshida N; Kaieda S; Tomozoe K; Tajiri M; Wakasugi D; Okamoto M; Tominaga M; Ida H; Hoshino T
    Intern Med; 2016; 55(12):1653-9. PubMed ID: 27301523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.
    Osawa T; Morimoto K; Sasaki Y; Matsuda S; Yamana K; Yano R; Uchiyama T; Goto H
    Intern Med; 2018 Feb; 57(3):387-391. PubMed ID: 29093381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone.
    Hildebrand BA; Arroyo R
    J Clin Rheumatol; 2010 Apr; 16(3):143-5. PubMed ID: 20216327
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
    Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kuwana M; Hosono Y; Mimori T; Kawakami A
    Medicine (Baltimore); 2018 Jun; 97(26):e11024. PubMed ID: 29952940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
    Yamada K; Asai K; Okamoto A; Watanabe T; Kanazawa H; Ohata M; Ohsawa M; Hirata K
    BMC Res Notes; 2018 Jan; 11(1):34. PubMed ID: 29338781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.
    Nishioka A; Tsunoda S; Abe T; Yoshikawa T; Takata M; Kitano M; Matsui K; Nakashima R; Hosono Y; Ohmura K; Mimori T; Sano H
    Mod Rheumatol; 2019 Sep; 29(5):814-820. PubMed ID: 30449228
    [No Abstract]   [Full Text] [Related]  

  • 17. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
    Horai Y; Isomoto E; Koga T; Okada A; Kawashiri SY; Tamai M; Yamasaki S; Nakamura H; Origuchi T; Hamaguchi Y; Fujimoto M; Kuwana M; Kawakami A
    Mod Rheumatol; 2013 Jan; 23(1):190-4. PubMed ID: 22460910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease.
    Kori M; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Takemura T; Izumo T
    Intern Med; 2020; 59(3):401-408. PubMed ID: 32009089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
    Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases.
    Mehta AA; Paul T; Cb M; Haridas N
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33910791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.